New ways to squash superbugs.
Walsh
Christopher T
CT
Harvard Medical School, USA.
Fischbach
Michael A
MA
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000096:biosynthesis / Q000494:pharmacology; D001419:Bacteria / Q000187:drug effects / Q000235:genetics / Q000378:metabolism; D001424:Bacterial Infections / Q000150:complications / Q000401:mortality; D001435:Bacteriophages; D015195:Drug Design; D024881:Drug Resistance, Bacterial; D004791:Enzyme Inhibitors; D005818:Genetic Engineering; D006801:Humans; D007251:Influenza, Human / Q000150:complications; D055624:Methicillin-Resistant Staphylococcus aureus / Q000187:drug effects; D010446:Peptide Fragments; D013678:Technology, Pharmaceutical
D000900:Anti-Bacterial Agents; D004791:Enzyme Inhibitors; D010446:Peptide Fragments